# VIP dosage guide

> Review VIP dosage information by administration route, with source-linked dose and schedule details.

Canonical: https://pepflow.app/peptides/vip/dosage/

Compare VIP injection and nasal schedules with nebulized aviptadil, keeping formulation and delivery requirements distinct. Calculate volume and syringe units using your own vial inputs.

[Full VIP library reference](<https://pepflow.app/peptides/vip/>)

## VIP dosage chart

This summary table compares available dose amounts and schedules by administration route.

| Route | Dose | Frequency & duration |
| --- | --- | --- |
| Injectable | 50–100 mcg | 1–2x daily · 3–6 mo |
| Intranasal | ~50 mcg | 2x daily · 3–6 mo |
| Inhaled | 100 mcg per nebulized administration | Two administrations 30 minutes apart, once daily · 7–14 days |

## VIP dosage by administration route

### VIP injectable dosage

Reported-use amounts for VIP are 50–100 mcg per administration, 1–2x daily, for 3–6 mo.[\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/vip/dosage/#source-3>) [\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

### VIP intranasal dosage

Reported-use amounts for VIP are ~50 mcg per administration, 2x daily, for 3–6 mo.[\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/vip/dosage/#source-3>) [\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

### VIP inhaled dosage

A documented investigational inhaled aviptadil regimen uses two 100 mcg administrations 30 minutes apart, once daily for 7–14 days, totaling 200 mcg per day. It uses a specific mesh-nebulizer formulation in hospital-based COVID-19 pneumonia care, rather than a general-use VIP spray or infusion.[\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>)

VIP is a vasoactive peptide with effects on vascular tone, airway signaling and secretion. Those effects make blood pressure and route-specific delivery important considerations.[\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/vip/dosage/#source-3>)

### Frequency and timing

Morning or evening is the listed timing for injections and nasal use. The inhaled aviptadil regimen uses two administrations 30 minutes apart, once daily.[\[4\]](<https://pepflow.app/peptides/vip/dosage/#source-4>) [\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>) [\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>)

### Cycle length and breaks

Injectable: 3–6 mo. Intranasal: 3–6 mo. Inhaled: 7–14 days. A standard break interval between courses is not established.[\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>) [\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>)

## VIP dosage calculator

Convert your chosen VIP amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.

For preparation terms and concentration basics, see the [reconstitution guidelines](<https://pepflow.app/peptide-reconstitution-guidelines/>). Follow the arithmetic in the [concentration calculation walkthrough](<https://pepflow.app/blog/how-to-calculate-final-concentration/>).

## VIP safety and side effects

### Approval and product quality

VIP is not an FDA-approved drug.[\[4\]](<https://pepflow.app/peptides/vip/dosage/#source-4>) [\[6\]](<https://pepflow.app/peptides/vip/dosage/#source-6>) [\[7\]](<https://pepflow.app/peptides/vip/dosage/#source-7>) [\[8\]](<https://pepflow.app/peptides/vip/dosage/#source-8>)

### Side effects and long-term safety

Flushing, headache, dizziness and blood-pressure effects are practical tolerability concerns. Long-term repeated use, disease-specific benefit-risk, intranasal absorption and compounded-product quality remain uncertain.[\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/vip/dosage/#source-3>)

### Route-specific dosing limits

Blood pressure, cardiovascular disease, pulmonary disease, and product route are the main safety contexts. Reported-use injectable and intranasal schedules are not established human treatment regimens.[\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/vip/dosage/#source-3>) [\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

## Common VIP dosage questions

### Can VIP doses be transferred between routes?

No. Each route and formulation has its own exposure and administration requirements. Use the dose information for the exact presentation rather than copying a tablet, injection or local-product amount to another route.[\[4\]](<https://pepflow.app/peptides/vip/dosage/#source-4>) [\[1\]](<https://pepflow.app/peptides/vip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/vip/dosage/#source-2>) [\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>)

### What dosage is listed for VIP?

Reported-use amounts for VIP are 50–100 mcg per administration, 1–2x daily, for 3–6 mo.[\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>)

### Does VIP have a standard cycle or break interval?

Injectable: 3–6 mo. Intranasal: 3–6 mo. Inhaled: 7–14 days. A standard break interval between courses is not established.[\[9\]](<https://pepflow.app/peptides/vip/dosage/#source-9>) [\[5\]](<https://pepflow.app/peptides/vip/dosage/#source-5>)

## Sources

- [\[1\] **Inhalation of vasoactive intestinal peptide in pulmonary hypertension.** Eur Respir J, 2008 Nov. review.](<https://pubmed.ncbi.nlm.nih.gov/18978135/>)
- [\[2\] **Anticipated pharmacological role of Aviptadil on COVID-19.** Environ Sci Pollut Res Int, 2022 Feb. review.](<https://pubmed.ncbi.nlm.nih.gov/34846667/>)
- [\[3\] **Pulmonary arterial hypertension: on the way to a manageable disease.** Curr Opin Investig Drugs, 2008 Sep. review.](<https://pubmed.ncbi.nlm.nih.gov/18729002/>)
- [\[4\] **Search Drugs@FDA for VIP** U.S. Food and Drug Administration. database query.](<https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm>)
- [\[5\] **Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19.** Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2025. human clinical.](<https://pubmed.ncbi.nlm.nih.gov/39870064/>)
- [\[6\] **Compounding and the FDA: Questions and Answers** U.S. Food and Drug Administration. official guidance.](<https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers>)
- [\[7\] **Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act** U.S. Food and Drug Administration, 2026-05-14. official guidance.](<https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act>)
- [\[8\] **Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C Act** U.S. Food and Drug Administration, 2025-01-07. regulatory.](<https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503b-fdc-act>)
- [\[9\] **PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)** PepFlow. reference catalog.](<https://pepflow.app/peptide-cheat-sheet/>)

[Full VIP library reference →](<https://pepflow.app/peptides/vip/>)

## Related

- [VIP Peptide](<https://pepflow.app/peptides/vip/>)
- [Peptide reconstitution guidelines](<https://pepflow.app/peptide-reconstitution-guidelines/>)
- [How to Calculate Final Concentration: A Practical Guide](<https://pepflow.app/blog/how-to-calculate-final-concentration/>)
- [Peptide Cheat Sheet](<https://pepflow.app/peptide-cheat-sheet/>)
